Robust inactivation of <i>Plasmodium falciparum</i> in red blood cell concentrates using amustaline and glutathione pathogen reduction-Reference-Cited by-同舟云学术

Robust inactivation of Plasmodium falciparum in red blood cell concentrates using amustaline and glutathione pathogen reduction

Published:2022-04-06 Issue:5 Volume:62 Page:1073-1083
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Sow Cissé¹,Bouissou Amélie¹,Girard Yvette A.²,Singh Gurvani B.²,Bounaadja Lotfi¹,Payrat Jean‐Marc³,Haas Delphine⁴,Isola Hervé⁴,Lanteri Marion C.²^ORCID,Bringmann Peter²,Grellier Philippe¹

Affiliation:

1. UMR7245 MCAM, Muséum National d'Histoire Naturelle, Team PPL, CNRS Paris France

2. Cerus Corporation Concord California USA

3. Cerus Europe BV Amersfoort Netherlands

4. EFS Grand Est Strasbourg France

Funder

Biomedical Advanced Research and Development Authority

Cerus Corporation

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/trf.16867

Reference38 articles.

1. World Trade Report 2020

2. Malaria Surveillance — United States, 2016

3. Peripheral blood stem cell transplant-relatedPlasmodium falciparuminfection in a patient with sickle cell disease

4. A case report of transfusion-transmitted Plasmodium malariae from an asymptomatic non-immune traveller

5. Donor-derived multiorgan transmission of mixed P. malariae and P. ovale infection: Impact of globalization on post-transplant infections

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dose‐dependent inactivation of Plasmodium falciparum in red blood cell concentrates by treatment with short‐wavelength ultraviolet light;Vox Sanguinis;2024-07-24

2. Pathogen reduced red blood cells as an alternative to irradiated and washed components with potential for up to 42 days storage;BLOOD TRANSFUS-ITALY;2024

3. Canadian Blood Services traceback investigation of a suspected case of transfusion‐transmitted malaria;Transfusion;2023-09-16

4. Mitigating the risk of transfusion‐transmitted infections with vector‐borne agents solely by means of pathogen reduction;Transfusion;2022-06-21